ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,764Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 15

$829K Total Retail Price of All Prescriptions

Rank: 6 out of 15

542 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 542 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 542 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 13,989 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
FUROSEMIDE 565 553 1 2
DONEPEZIL HCL 539 529 2 11
AMLODIPINE BESYLATE 426 388 3 3
LEVOTHYROXINE SODIUM 404 395 4 1
NAMENDA 376 356 5 12
LISINOPRIL 367 354 6 4
ESCITALOPRAM OXALATE 341 313 7 16
SIMVASTATIN 304 287 8 6
SERTRALINE HCL 273 257 9 22
METOPROLOL SUCCINATE 260 255 10 25
MIRTAZAPINE 254 253 11 33
METOPROLOL TARTRATE 247 245 12 9
HYDROCODONE-ACETAMINOPHEN 239 226 S3 13 5
KLOR-CON M20 231 221 14 26
WARFARIN SODIUM 223 216 15 13
POLYETHYLENE GLYCOL 3350 210 196 16 17
TRAZODONE HCL 197 172 17 27
GABAPENTIN 197 184 17 21
CITALOPRAM HBR 172 158 19 29
RISPERIDONE 149 144 20 28
POTASSIUM CHLORIDE 148 140 21 10
DIOVAN 146 139 22 34
DIVALPROEX SODIUM 142 131 23 42
CLOPIDOGREL 141 126 24 30
QUETIAPINE FUMARATE 140 119 25 20
METFORMIN HCL 135 120 26 7
LACTULOSE 134 134 27 14
OMEPRAZOLE 129 120 28 8
DIGOXIN 126 126 29 46
ZOLPIDEM TARTRATE 126 126 29 37
CYMBALTA 125 124 31 53
ATORVASTATIN CALCIUM 124 124 32 38
NEXIUM 116 116 33 24
LANTUS 113 112 34 36
PLAVIX 110 102 35 43
CLONIDINE HCL 107 102 36 32
LEVETIRACETAM 107 86 36 39
HYDROCHLOROTHIAZIDE 99 95 38 23
SULFAMETHOXAZOLE-TRIMETHOPRIM 99 94 38 58
CARVEDILOL 98 91 40 19
TRAMADOL HCL 98 97 40 18
LEXAPRO 91 84 42 81
OLANZAPINE 90 77 43 47
VENLAFAXINE HCL ER 85 85 44 115
ATENOLOL 83 79 45 40
LANTUS SOLOSTAR 83 83 45 56
METOLAZONE 81 81 47 126
LEVOFLOXACIN 79 77 48 76
SYNTHROID 79 79 48 51
CLONIDINE 78 78 50 119
CRESTOR 77 70 51 44
PANTOPRAZOLE SODIUM 75 71 52 50
PREDNISONE 74 68 53 62
GLIPIZIDE 72 72 54 45
KLOR-CON M10 72 66 54 85
PRAVASTATIN SODIUM 69 69 56 15
TRICOR 67 56 57 86
SEROQUEL 67 62 57 60
TAMSULOSIN HCL 65 52 59 31
FAMOTIDINE 63 61 60 72
FLUTICASONE PROPIONATE 62 59 61 73
CARBIDOPA-LEVODOPA 61 61 62 64
TRANSDERM-SCOP 58 51 63 201
OXYBUTYNIN CHLORIDE 57 57 64 141
BACLOFEN 56 26 65 102
LOSARTAN POTASSIUM 55 55 66 97
MELOXICAM 53 53 67 69
NOVOLIN N 50 50 68 49
LATANOPROST 50 46 68 114
CEPHALEXIN 50 49 68 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.